Skip to content
OpenCapital
Get started

Acadia Pharmaceuticals ACAD Current ratio

Current ratio at other companies

Biogen logo
BiogenBIIB
3.1×+1.6×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
2.9×-0.2×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
7.1×+1.0×
PTC Therapeutics logo
PTC TherapeuticsPTCT
2.4×-1.5×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.5×-3.0×
TG Therapeutics logo
TG TherapeuticsTGTX
5.8×+1.8×

Other financials

Income statement

See full
Revenue$268.1M+9.7%
Gross profit$243.3M+8.6%
Operating income-$4.6M-124%
Net income$3.6M-80.8%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$282.2M+29.6%
Total debt$50.8M-9.3%
Total equity$1.2B+63.1%
Total assets$1.6B+41.8%

Cash flow

See full
Operating cash flow$34.0M+67.2%
CapEx$5.2M—
Free cash flow$28.8M+41.6%

Valuation

See full
Market cap$3.7B+37.0%
Enterprise value$3.47B+36.6%
P/E9.9×-2.0×
P/S3.4×+0.7×

Profitability

See full
Gross margin91.5%-0.6pp
Operating margin7.4%-16.2pp
Net margin34.3%+11.3pp
FCF margin18.9%—

Returns & leverage

See full
Return on equity37.3%+0.1pp
Debt / equity0×0.0×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

total current assets/total current liabilities=3.6×

Based on the most recent quarter.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Acadia Pharmaceuticals's current ratio?
Acadia Pharmaceuticals (ACAD) reported current ratio of 3.6× in Q1 2026.
How has Acadia Pharmaceuticals's current ratio changed year-over-year?
Acadia Pharmaceuticals's current ratio increased by 24.6% year-over-year, from 2.9× to 3.6×.
What is the long-term trend for Acadia Pharmaceuticals's current ratio?
Over 5 years (2020 to 2025), Acadia Pharmaceuticals's current ratio has grown at a -10.8% compound annual growth rate (CAGR), from 6.8× to 3.8×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.